Trademark Trial and Appeal Board Electronic Filing System. http://estta.uspto.gov
`ESTTA948720
`01/21/2019
`
`ESTTA Tracking number:
`
`Filing date:
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`Proceeding
`
`Party
`
`Correspondence
`Address
`
`91245889
`
`Defendant
`Vytalyx Inc
`
`VYTALYX INC
`VYTALYX INC
`815A BRAZOS STREET STE 265
`AUSTIN, TX 78701
`dgranzotti@vytalyx.com, agranzotti@vytalyx.com
`no phone number provided
`
`Submission
`
`Filer's Name
`
`Filer's email
`
`Signature
`
`Date
`
`Other Motions/Papers
`
`David Granzotti
`
`legal@vytalyx.com, TBlofield@winthrop.com
`
`/David Granzotti/
`
`01/21/2019
`
`Attachments
`
`SCAN-01212019095237.pdf(42429 bytes )
`
`

`

`January 21, 2019 zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
`
`TO:
`
`RE:
`
`United States Patent & Trademark Office
`Interlocutory Attorney: Andrew zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAR Baxley
`
`Paralegal: Veronica P White
`
`Consent Motion to Amend Application
`Opposition No.: 91245889
`In the matter of Application Ser No.: 87/719,755
`Filed: D ecem ber 13, 2017
`For the mark: VYT AL YX
`
`Dear Mr. Baxley:
`
`Vytalyx Inc. (A pp licant") hereby requests a consent motion to amend the aforementioned application
`serial number pursuant to the below:
`
`l. Amend International Class 5 for VYTALYX at Ser. No. 87/719,755 to remove the goods stricken
`below and add the exclusion "all of the aforesaid, excluding, goods for the treatment of cancer"
`
`"Compounded pharmaceuticals, namely, Sterile injectables, non-sterile solutions, suspensions,
`ointments, creams, powders, capsules, tablets and troches for use in the areas of, Weight
`management, Erectile dysfunction treatment, Male hormone replacement treatment, Female
`hormone replacement treatment, B io-identical horm one replacem ent, Adrenal dysfunction
`treatment, Thyroid dysfunction treatment, Pain management, Palliative care, Sports medicine,
`Amino acid replacement therapy, Mineral replacement therapy, Vitamin replacement therapy,
`Anti-aging therapy, Dermatology, Fertility, Growth Hormone therapy; and Anticonvulsant agents,
`Antihypertensive agents, Antidiabetic agents, Non-steroidal anti-inflammatory agents, Anesthetic
`agents, Vasoactive agents, Lipotropic agents, Chelating agents, Psychoactive agents; Compounded
`personalized pharm aceuticals, nam ely, Sterile
`injectables, non-sterile solutions, suspensions,
`ointments, creams, powders, capsules, tablets and for use in the areas of, Weight management,
`Erectile dysfunction
`treatment, Male hormone replacement treatment, Female hormone
`replacement treatment, Bio-identical hormone replacement, Adrenal dysfunction treatment,
`Thyroid dysfunction treatment, Pain management, Palliative care, Sports· medicine, Amino acid
`replacement therapy, Mineral replacement therapy, Vitamin replacement therapy, Anti-aging
`therapy, Dermatology, Fertility, Growth Hormone
`therapy; and Anticonvulsant agents,
`Antihypertensive agents, Antidiabetic agents, Non-steroidal anti-inflammatory agents, Anesthetic
`agents, Vasoactive agents, Lipotropic agents, Chelating agents, Psychoactive agents; Compounded
`personalized pharmaceuticals, namely, Sterile injectables, non-sterile solutions, suspensions,
`ointments, creams, powders, capsules, tablets and troches based on medical, genetic, genomic,
`nutrigenomic,
`pharmacogenomic, microbiomic, metabolomic, proteomic, biochemistry,
`biomarker, health, dietary, nutrition, exercise, physical fitness, lifestyle and personal information
`for use in the areas of, Weight management, Erectile dysfunction treatment, Male hormone
`replacement
`treatment, Female hormone
`replacement
`treatment, Bio-identical hormone
`replacement, Adrenal dysfunction treatment, Thyroid dysfunction treatment, Pain management,
`Palliative care, Sports medicine, Amino acid replacement therapy, Mineral replacement therapy,
`Vitamin replacement therapy, Anti-aging therapy, Dermatology, Fertility, Growth Hormone
`therapy; and Anticonvulsant agents, Antihypertensive agents, Antidiabetic agents, Non-steroidal
`anti-inflammatory agents, Anesthetic agents, Vasoactive agents, Lipotropic agents, Chelating
`agents, .Psychoactive agents; Genetic marker tests comprised of reagents for medical purposes;
`Medical diagnostic reagents and assays for testing of body fluids in the nature of genomic,
`
`

`

`microbiomic, metabolomic, and biochemical tests; Medical diagnostic test kits comprised of
`medical diagnostic reagents and assays used to collect test samples for analyzing DNA, blood, hair,
`stool inform ation for use in DNA, blood, hair, saliva and stool testing of humans; Kits
`saliva and zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
`comprised of medical diagnostic reagents and assays for use in genetic, genomic, microbiomic,
`metabolomic, and biochemical testing; Kits comprised of medical diagnostic reagents and assays
`for use in DNA, blood, hair, saliva and stool testing of humans; Medical diagnostic test media in
`the form of strips, threads, swabs, cartridges, and collection tubes for collecting and analyzing
`g enetic, genom ic, microbiomic, metabolomic, and biochemical data; all of the aforesaid, excluding,
`goods for the treatment of cancer," in IC 5
`
`Celator Pharmaceuticals, Inc. zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
`("Opposer") hereby agrees to the above am endm ent. Furtherm ore, upon
`approval of the above amendment by the U.S. Trademark Trial and Appeal Board, Opposer agrees to
`withdraw its Notice of Opposition No. 91245889 with respect to the aforementioned serial number.
`
`Acknowledged and agreed
`
`VYT AL YX, INC.
`.@ .a .k _
`
`Name: David Granzotti
`
`Position: President
`
`16742775vl
`
`/
`Name: Tiffany Blofield
`
`Position: Attorney on behalf of Celator
`Pharmaceuticals Inc.
`
`